B. Riley Has Positive Forecast for Lam Research Q2 Earnings

Key Points

• Investment analysts at B. Riley have raised their Q2 2026 earnings per share estimate for Lam Research from $1.06 to $1.14, maintaining a "Buy" rating with a target price of $175.00.
• Lam Research reported a Q3 2026 earnings forecast of $1.09 EPS, with a full-year estimate for FY2026 at $4.63 EPS, indicating strong expected growth.
• The company recently increased its quarterly dividend from $0.23 to $0.26, reflecting a commitment to returning value to shareholders amid strong earnings performance.

Lam Research Corporation (NASDAQ:LRCX - Free Report) - Investment analysts at B. Riley raised their Q2 2026 earnings per share estimates for shares of Lam Research in a research note issued on Wednesday, October 22nd. B. Riley analyst C. Ellis now expects that the semiconductor company will earn $1.14 per share for the quarter, up from their prior estimate of $1.06. B. Riley currently has a "Buy" rating and a $175.00 target price on the stock. The consensus estimate for Lam Research's current full-year earnings is $3.71 per share. B. Riley also issued estimates for Lam Research's Q3 2026 earnings at $1.09 EPS, Q4 2026 earnings at $1.13 EPS, FY2026 earnings at $4.63 EPS, Q1 2027 earnings at $1.18 EPS, Q2 2027 earnings at $1.23 EPS, Q3 2027 earnings at $1.24 EPS, Q4 2027 earnings at $1.32 EPS and FY2027 earnings at $4.97 EPS.

Several other brokerages also recently weighed in on LRCX. KeyCorp upped their price objective on Lam Research from $105.00 to $115.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. Berenberg Bank upped their price objective on Lam Research from $122.00 to $165.00 and gave the stock a "buy" rating in a research report on Thursday. Citigroup upped their price objective on Lam Research from $120.00 to $175.00 and gave the stock a "buy" rating in a research report on Thursday. Cantor Fitzgerald restated an "overweight" rating and set a $170.00 price objective on shares of Lam Research in a research report on Thursday. Finally, Susquehanna upped their price objective on Lam Research from $135.00 to $200.00 and gave the stock a "positive" rating in a research report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, Lam Research currently has an average rating of "Moderate Buy" and a consensus price target of $144.85.

Lam Research Price Performance

Shares of LRCX stock opened at $147.54 on Friday. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38. Lam Research has a twelve month low of $56.32 and a twelve month high of $153.70. The company has a market cap of $186.05 billion, a P/E ratio of 32.50, a P/E/G ratio of 1.71 and a beta of 1.84. The business has a fifty day simple moving average of $122.19 and a 200 day simple moving average of $98.97.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating analysts' consensus estimates of $1.22 by $0.04. Lam Research had a return on equity of 61.89% and a net margin of 29.66%.The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the prior year, the company posted $0.86 EPS. The company's revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS.

Institutional Investors Weigh In On Lam Research

Institutional investors and hedge funds have recently made changes to their positions in the stock. IMG Wealth Management Inc. acquired a new stake in shares of Lam Research in the second quarter valued at about $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research in the second quarter valued at about $27,000. Sound Income Strategies LLC acquired a new stake in shares of Lam Research in the third quarter valued at about $41,000. Tripletail Wealth Management LLC acquired a new stake in shares of Lam Research in the third quarter valued at about $44,000. Finally, Strategic Wealth Investment Group LLC acquired a new stake in shares of Lam Research in the second quarter valued at about $29,000. Institutional investors and hedge funds own 84.61% of the company's stock.

Insider Transactions at Lam Research

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the company's stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the transaction, the senior vice president owned 251,047 shares of the company's stock, valued at $34,870,428.30. This represents a 17.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.31% of the stock is currently owned by insiders.

Lam Research Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th were issued a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 24th. This is a boost from Lam Research's previous quarterly dividend of $0.23. Lam Research's payout ratio is currently 22.91%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.